2017 Q4 Form 10-Q Financial Statement

#000117184318000341 Filed on January 12, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2016 Q4
Revenue $11.54M $9.702M
YoY Change 18.98% 38.12%
Cost Of Revenue $7.888M $6.613M
YoY Change 19.29% 35.63%
Gross Profit $3.655M $3.089M
YoY Change 18.3% 43.75%
Gross Profit Margin 31.66% 31.84%
Selling, General & Admin $4.820M $4.511M
YoY Change 6.85% 21.93%
% of Gross Profit 131.88% 146.02%
Research & Development $798.7K $642.5K
YoY Change 24.31% -36.01%
% of Gross Profit 21.86% 20.8%
Depreciation & Amortization $208.5K $193.9K
YoY Change 7.52% 21.91%
% of Gross Profit 5.7% 6.28%
Operating Expenses $5.618M $5.153M
YoY Change 9.02% 9.56%
Operating Profit $1.285M $525.5K
YoY Change 144.47% -713.93%
Interest Expense $5.089K $4.623K
YoY Change 10.08% -2.18%
% of Operating Profit 0.4% 0.88%
Other Income/Expense, Net
YoY Change
Pretax Income $1.300M $520.0K
YoY Change 150.0% -750.0%
Income Tax $105.0K $117.7K
% Of Pretax Income 8.08% 22.64%
Net Earnings $1.084M $297.6K
YoY Change 264.07% -227.01%
Net Earnings / Revenue 9.39% 3.07%
Basic Earnings Per Share $0.24 $0.07
Diluted Earnings Per Share $0.24 $0.07
COMMON SHARES
Basic Shares Outstanding 4.537M 4.532M
Diluted Shares Outstanding 4.609M 4.559M

Balance Sheet

Concept 2017 Q4 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $8.400M $4.280M
YoY Change 96.26% 18.89%
Cash & Equivalents $4.627M $2.529M
Short-Term Investments $3.770M $1.750M
Other Short-Term Assets $760.0K $640.0K
YoY Change 18.75% -35.35%
Inventory $7.969M $7.388M
Prepaid Expenses $760.6K $640.7K
Receivables $7.770M $6.160M
Other Receivables $1.310M $1.540M
Total Short-Term Assets $26.21M $20.00M
YoY Change 31.04% 9.4%
LONG-TERM ASSETS
Property, Plant & Equipment $7.235M $7.184M
YoY Change 0.72% -2.85%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $21.70M $20.05M
YoY Change 8.23% -1.55%
Other Assets $49.83K
YoY Change -79.32%
Total Long-Term Assets $24.75M $23.02M
YoY Change 7.5% -7.59%
TOTAL ASSETS
Total Short-Term Assets $26.21M $20.00M
Total Long-Term Assets $24.75M $23.02M
Total Assets $58.20M $50.21M
YoY Change 15.91% -0.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.798M $2.959M
YoY Change 28.33% 27.29%
Accrued Expenses $2.010M $1.160M
YoY Change 73.28% -3.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.828M $4.118M
YoY Change 41.52% 16.74%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.828M $4.118M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $8.620M $6.520M
YoY Change 32.21% -2.83%
SHAREHOLDERS EQUITY
Retained Earnings $37.71M $33.95M
YoY Change 11.05% -0.98%
Common Stock $14.39M $13.95M
YoY Change 3.13% 2.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $49.57M $43.69M
YoY Change
Total Liabilities & Shareholders Equity $58.20M $50.21M
YoY Change 15.91% -0.76%

Cashflow Statement

Concept 2017 Q4 2016 Q4
OPERATING ACTIVITIES
Net Income $1.084M $297.6K
YoY Change 264.07% -227.01%
Depreciation, Depletion And Amortization $208.5K $193.9K
YoY Change 7.52% 21.91%
Cash From Operating Activities -$1.430M -$924.4K
YoY Change 54.67% 23.26%
INVESTING ACTIVITIES
Capital Expenditures $87.25K $112.6K
YoY Change -22.51% -57.38%
Acquisitions
YoY Change
Other Investing Activities $0.00 $500.0K
YoY Change -100.0% -66.67%
Cash From Investing Activities -$121.9K $327.1K
YoY Change -137.28% -73.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $71.71K
YoY Change -100.0% 50.44%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -172.1K -238.8K
YoY Change -27.9% 2287.57%
NET CHANGE
Cash From Operating Activities -1.430M -924.4K
Cash From Investing Activities -121.9K 327.1K
Cash From Financing Activities -172.1K -238.8K
Net Change In Cash -1.724M -836.1K
YoY Change 106.18% -281.76%
FREE CASH FLOW
Cash From Operating Activities -$1.430M -$924.4K
Capital Expenditures $87.25K $112.6K
Free Cash Flow -$1.517M -$1.037M
YoY Change 46.29% 2.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
701799
CY2017Q4 ntic Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
2
CY2017Q4 ntic Net Sales To Joint Ventures
NetSalesToJointVentures
507631
CY2016Q4 ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
-91385
CY2017Q4 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
11035407
CY2016Q4 ntic Net Sales Excluding Joint Ventures
NetSalesExcludingJointVentures
9000224
CY2017Q4 ntic Allocated Share Based Compensation Expense Estimate Fiscal Year Two
AllocatedShareBasedCompensationExpenseEstimateFiscalYearTwo
65234
CY2017Q4 ntic Allocated Share Based Compensation Expense Estimate Next Fiscal Year
AllocatedShareBasedCompensationExpenseEstimateNextFiscalYear
153901
CY2017Q4 ntic Allocated Share Based Compensation Expense Estimate Remainder Of Fiscal Year
AllocatedShareBasedCompensationExpenseEstimateRemainderOfFiscalYear
309801
CY2017Q4 ntic Cost Of Goods Sold As Percentage Of Product Sales
CostOfGoodsSoldAsPercentageOfProductSales
CY2016Q4 ntic Cost Of Goods Sold As Percentage Of Product Sales
CostOfGoodsSoldAsPercentageOfProductSales
CY2017Q4 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
CY2016Q4 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1
CY2017Q4 ntic Entity Wide Trade Joint Venture Receivables Four Joint Venturespercentage
EntityWideTradeJointVentureReceivablesFourJointVenturespercentage
0.936
CY2017Q3 ntic Entity Wide Trade Joint Venture Receivables Three Joint Ventures Percentage
EntityWideTradeJointVentureReceivablesThreeJointVenturesPercentage
0.607
CY2017Q4 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1507142
CY2016Q4 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1315591
CY2017Q4 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1310818
CY2017Q3 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1302944
CY2017Q4 ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
7874
CY2016Q4 ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
15518
CY2017Q4 ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
1364409
CY2016Q4 ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
762525
CY2017Q4 ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
-171099
CY2017Q4 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1507142
CY2016Q4 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1315591
CY2017Q4 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
7251821
CY2017Q3 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
5912631
CY2017Q4 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
520653
CY2017Q3 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
691752
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3797674
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2676610
CY2017Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
318000
CY2016Q4 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
98000
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
15565
CY2017Q3 us-gaap Assets
Assets
56612693
CY2017Q4 us-gaap Assets Current
AssetsCurrent
26210641
CY2017Q3 us-gaap Assets Current
AssetsCurrent
26067618
CY2017Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
24749813
CY2017Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
23185413
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3770241
CY2017Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
3766984
CY2017Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
3770241
CY2017Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4177519
CY2017Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3969267
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2518243
CY2017Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2471064
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14294584
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14163509
CY2017Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
62177
CY2016Q4 us-gaap Adjustment For Amortization
AdjustmentForAmortization
29759
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40000
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40000
CY2017Q4 us-gaap Assets
Assets
58195755
CY2017Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
3766984
CY2017Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6855488
CY2017Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
6847177
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6360201
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3395274
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4627213
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2529140
CY2017Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1732988
CY2016Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-866134
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2017Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2016Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4537408
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4535018
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4537408
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4535018
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
90748
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
90700
CY2017Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1036447
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
55633891
CY2017Q4 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
57249505
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Current Assets
EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
51518210
CY2017Q4 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
17410457
CY2016Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-904491
CY2017Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
136916
CY2016Q4 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
60372
CY2017Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1173363
CY2016Q4 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-844119
CY2017Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7888470
CY2016Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6612766
CY2017Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1756565
CY2017Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1756565
CY2017Q4 us-gaap Depreciation
Depreciation
208486
CY2016Q4 us-gaap Depreciation
Depreciation
193896
CY2017Q4 us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<div style="display: inline; text-transform: uppercase">Accounting PronouncementS</div></div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">New Accounting Pronouncements Adopted</div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,</div> &#x201c;<div style="display: inline; font-style: italic;">Inventory</div>,&#x201d; which modifies the subsequent measurement of inventories recorded under a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-in-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-out or average cost method. Under the new standard, such inventories are required to be measured at the lower of cost and net realizable value. The Company has adopted this new standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> on a prospective basis. The adoption of this standard did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company&#x2019;s consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07,</div> &#x201c;<div style="display: inline; font-style: italic;">Investments &#x2013; Equity Method and Joint Ventures (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">323</div>): Simplifying the Transition to the Equity Method of Accounting</div>.&#x201d; Among other things, the amendments in ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">07</div> eliminate the requirement that when an investment qualifies for use of the equity method as a result of an increase in the level of ownership interest or degree of influence, an investor must adjust the investment, results of operations, and retained earnings retroactively on a step-by-step basis as if the equity method had been in effect during all previous periods that the investment had been held. The amendments require that the equity method investor add the cost of acquiring the additional interest in the investee to the current basis of the investor&#x2019;s previously held interest and adopt the equity method of accounting as of the date the investment becomes qualified for equity method accounting. Therefore, upon qualifying for the equity method of accounting, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> retroactive adjustment of the investment is required. The amendments require that an entity that has an available-for-sale equity security that becomes qualified for the equity method of accounting recognize through earnings the unrealized holding gain or loss in accumulated other comprehensive income at the date the investment becomes qualified for use of the equity method. The Company adopted this new standard in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> on a prospective basis. The adoption of this standard did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material impact on the Company&#x2019;s consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> <div style="display: inline; font-style: italic;">Stock Compensation</div>, <div style="display: inline; font-style: italic;">(Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718</div>)</div>, which is intended to simplify several aspects of the accounting for share-based payment award transactions. The Company adopted this new guidance in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of fiscal <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> The adoption of this guidance did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have a material effect on the Company&#x2019;s consolidated results of operations and financial position.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <!-- Field: Page; Sequence: 8; Value: 1 --> <!-- Field: /Page --> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><div style="display: inline; font-style: italic;">Recently Issued Accounting Pronouncements </div></div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 2014, </div>the FASB issued <div style="display: inline; font-style: italic;">Revenue from Contracts with Customers, Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606</div></div> (ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div>), which provides a framework for the recognition of revenue, with the objective that recognized revenues properly reflect amounts an entity is entitled to receive in exchange for goods and services. This guidance, which includes additional disclosure requirements regarding revenue, cash flows and obligations related to contracts with customers, was originally to be effective for the Company beginning in fiscal year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2015, </div>the FASB confirmed a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div>-year deferral of the effective date of the new revenue standard which also allows early adoption as of the original effective date. The updated guidance will be effective for the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> The Company is currently evaluating the impact of adopting ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09</div> on its consolidated financial statements, but currently believes that the timeline established for implementation is attainable.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;<div style="display: inline; font-style: italic;">Leases</div>.&#x201d; ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> was issued to increase transparency and comparability among organizations by recognizing all lease transactions (with terms in excess of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months) on the balance sheet as a lease liability and a right-of-use asset (as defined). ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> is effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018, </div>including interim periods within those fiscal years, with earlier application permitted. Upon adoption, the lessee will apply the new standard retrospectively to all periods presented or retrospectively using a cumulative effect adjustment in the year of adoption. The guidance will be effective for the Company&#x2019;s <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020.</div> The Company is currently assessing the effect that ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02</div> will have on its consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2016, </div>the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic;">Statement of Cash Flows, Classification of Certain Cash Receipts and Cash Payments.</div>&nbsp;&nbsp;ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> eliminates the diversity in practice related to the classification of certain cash receipts and payments for debt prepayments or extinguishment costs, the maturing of a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">zero</div> coupon bond, the settlement of contingent liabilities arising from a business combination, proceeds from insurance settlements, distributions from certain equity method investees and beneficial interests obtained in a financial asset securitization. ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> designates the appropriate cash flow classification, including requirements to allocate certain components of these cash receipts and payments among operating, investing and financing activities. The guidance is effective for fiscal years beginning <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2017. </div>Early adoption is permitted. The Company is currently evaluating the effects of adopting ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> on its consolidated financial statements, but the adoption is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expected to have a significant impact on its consolidated financial statements.</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</div> <div style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although there are several other new accounting pronouncements issued or proposed by the FASB, which the Company has adopted or will adopt, as applicable, the Company does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe any of these accounting pronouncements has had or will have a material impact on the Company&#x2019;s consolidated financial position or operating results.</div></div>
CY2017Q4 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2017-12-21
CY2017Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
454741
CY2016Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
CY2017Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2017-12-08
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2017Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-9131
CY2016Q4 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-30056
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
955903
CY2017Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1540386
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
528936
CY2017Q4 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
63937
CY2017 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6377054
CY2017Q4 us-gaap Equity Method Investment Summarized Financial Information Assets
EquityMethodInvestmentSummarizedFinancialInformationAssets
61290726
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Current Liabilities
EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
15118074
CY2017Q4 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
43696018
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Equity
EquityMethodInvestmentSummarizedFinancialInformationEquity
40334607
CY2017Q4 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
12788122
CY2016Q4 us-gaap Equity Method Investment Summarized Financial Information Gross Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss
10697027
CY2017Q4 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
3499815
CY2016Q4 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
2408008
CY2017Q4 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
184251
CY2017Q3 us-gaap Equity Method Investment Summarized Financial Information Noncurrent Liabilities
EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
181210
CY2017Q4 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
28498711
CY2016Q4 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
24200447
CY2017Q4 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
21701913
CY2017Q3 us-gaap Equity Method Investment Underlying Equity In Net Assets
EquityMethodInvestmentUnderlyingEquityInNetAssets
20035074
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
21701913
CY2017Q3 us-gaap Equity Method Investments
EquityMethodInvestments
20035074
CY2017Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1291335
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1322089
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2219745
CY2016Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2471780
CY2017Q4 us-gaap Gross Profit
GrossProfit
3654568
CY2016Q4 us-gaap Gross Profit
GrossProfit
3089257
CY2017Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1741328
CY2016Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1274004
CY2017Q4 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
1303580
CY2016Q4 us-gaap Income Loss Including Portion Attributable To Noncontrolling Interest
IncomeLossIncludingPortionAttributableToNoncontrollingInterest
524406
CY2017Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
104991
CY2016Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
117713
CY2017Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2016Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
CY2017Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
CY2017Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
137256
CY2017Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1278940
CY2016Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
378397
CY2017Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
102618
CY2016Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-102314
CY2017Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-622696
CY2016Q4 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-172691
CY2016Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-924426
CY2016Q4 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
497896
CY2017Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
CY2016Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-25242
CY2017Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
101908
CY2016Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-84922
CY2017Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
530401
CY2016Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-274437
CY2017Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
250280
CY2016Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
180021
CY2017Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
71420
CY2016Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
26928
CY2017Q4 us-gaap Interest Expense
InterestExpense
5089
CY2016Q4 us-gaap Interest Expense
InterestExpense
4623
CY2017Q4 us-gaap Interest Paid Net
InterestPaidNet
5089
CY2016Q4 us-gaap Interest Paid Net
InterestPaidNet
4623
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6117593
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
5709363
CY2017Q4 us-gaap Inventory Gross
InventoryGross
7969328
CY2017Q3 us-gaap Inventory Gross
InventoryGross
7456552
CY2017Q4 us-gaap Inventory Net
InventoryNet
7969328
CY2017Q3 us-gaap Inventory Net
InventoryNet
7456552
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1851735
CY2017Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1747189
CY2017Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
24056
CY2016Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
3563
CY2017Q4 us-gaap Land
Land
310365
CY2017Q3 us-gaap Land
Land
310365
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58195755
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56612693
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5827935
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4894617
CY2017Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4246967
CY2017Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4171387
CY2017Q4 us-gaap Minority Interest
MinorityInterest
2794364
CY2017Q3 us-gaap Minority Interest
MinorityInterest
2857448
CY2017Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-172144
CY2016Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-238757
CY2017Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121930
CY2016Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
327105
CY2017Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1429783
CY2017Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
15375
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
1083626
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
297639
CY2017Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
114963
CY2016Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
109054
CY2017Q4 us-gaap Noncurrent Assets
NoncurrentAssets
7235301
CY2017Q3 us-gaap Noncurrent Assets
NoncurrentAssets
7359662
CY2017Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
5618425
CY2016Q4 us-gaap Operating Expenses
OperatingExpenses
5153386
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
1284613
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
525466
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1058793
CY2017Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
677621
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
71685
CY2017Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-25226
CY2016Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1250812
CY2017Q4 us-gaap Other Operating Income
OtherOperatingIncome
3248470
CY2016Q4 us-gaap Other Operating Income
OtherOperatingIncome
2589595
CY2017Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2016Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
71712
CY2017Q4 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
200000
CY2016Q4 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
200000
CY2017Q4 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
3257
CY2016Q4 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
CY2017Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
31423
CY2016Q4 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
58202
CY2017Q4 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
CY2016Q4 us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
0
CY2017Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
87250
CY2016Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
112589
CY2017Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2017Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
760567
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
439298
CY2017Q4 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
63937
CY2016Q4 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
CY2017Q4 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
CY2016Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
CY2017Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
12481
CY2016Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
32955
CY2017Q4 us-gaap Profit Loss
ProfitLoss
1198589
CY2016Q4 us-gaap Profit Loss
ProfitLoss
406693
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11412820
CY2017Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
11328929
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7235301
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7359662
CY2017Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
798731
CY2016Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
642522
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
4627213
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
6360201
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37706367
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37077483
CY2017Q4 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
19590029
CY2017Q3 us-gaap Retained Earnings Undistributed Earnings From Equity Method Investees
RetainedEarningsUndistributedEarningsFromEquityMethodInvestees
17960860
CY2017Q4 us-gaap Sales Revenue Net
SalesRevenueNet
11543038
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
9702023
CY2017Q4 us-gaap Selling Expense
SellingExpense
2599949
CY2016Q4 us-gaap Selling Expense
SellingExpense
2039084
CY2017Q4 us-gaap Share Based Compensation
ShareBasedCompensation
103267
CY2016Q4 us-gaap Share Based Compensation
ShareBasedCompensation
97916
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0218
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.459
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.464
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0187
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.75
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.69
CY2017Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.25
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
CY2017Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y346D
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y54D
CY2017Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
891
CY2016Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
3029
CY2017Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1500
CY2016Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2017Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
103267
CY2016Q4 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
97916
CY2017Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2016Q4 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
5575
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
49573456
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
48860628
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
52367820
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
51718076
CY2016Q4 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
12.87
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4608788
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4558878
CY2017Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4537368
CY2016Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4531950

Files In Submission

Name View Source Status
0001171843-18-000341-index-headers.html Edgar Link pending
0001171843-18-000341-index.html Edgar Link pending
0001171843-18-000341.txt Edgar Link pending
0001171843-18-000341-xbrl.zip Edgar Link pending
exh_101.htm Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_011218p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lynch.jpg Edgar Link pending
ntic-20171130.xml Edgar Link completed
ntic-20171130.xsd Edgar Link pending
ntic-20171130_cal.xml Edgar Link unprocessable
ntic-20171130_def.xml Edgar Link unprocessable
ntic-20171130_lab.xml Edgar Link unprocessable
ntic-20171130_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wolsfeld.jpg Edgar Link pending